CCL5 and metabolic dysfunction-associated steatohepatitis: Although Ccl5 is also expressed by other liver cell types14–17 and is better known for causing hepatic fibrosis through the recruitment of immune cells14,15, its pro-steatotic action in early NAFLD/NASH has not been recognized until now.